- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02050698
Hard-soled Shoe Versus Short Leg Walking Cast for a Fifth Metatarsal Avulsion Fracture: A Randomized Multicenter Noninferiority Trial
Fifth metatarsal avulsion fractures are common and can usually be treated conservatively. Symptomatic care consisting of protected weightbearing in a hard-soled shoe, air-cast walking boot, or below-knee walking cast have been successful. Several papers reported that early rehabilitation may decrease ankle stiffness, muscle and bone atrophy, and aids in early return to activities. However, early motion of the ankle joint may have the risk of displacement of the fifth metatarsal avulsion fractures. However, studies using hard-sole shoe for protected weightbearing and allowing motion of the ankle joint had successful results. Clapper et al. compared the results of hard-soled shoe and walking cast for a fifth metatarsal avulsion fracture and reported that all avulsion fractures healed uneventfully and that the results were similar between the two. However, this was not a randomized controlled trial.
Devices such as air-cast walking boot, plaster slipper, or Jone's dressing can also be used for the treatment. However, we decided to compare results of hard-soled shoe and short leg walking cast for the treatment of a fifth metatarsal avulsion fracture.
We hypothesized that the 100mm visual analogue scale (VAS) assessed on 6 months after a fifth metatarsal avulsion fracture treated with protected weightbearing in a hard-soled shoe is not inferior to protected weightbearing in a short leg walking cast but is superior to short leg walking cast with respect to time to return to normal daily life and patient's satisfaction.
Study Overview
Status
Conditions
Detailed Description
This study is a noninferiority, randomized controlled trial of patients presenting to multiple centers. The primary outcome measure is the 100mm VAS assessed on 6 months after a fifth metatarsal avulsion fracture. 100mm VAS was compared between the experimental group (hard-soled shoe) and the control group (short leg walking cast) on 6 months follow-up examination. The 100mm VAS is widely used self assessment tool for evaluating pain after fracture. The secondary objectives were to determine whether hard-soled shoe was superior to short leg walking cast with respect to time until return to normal daily life and patient's satisfaction.
The sample size was determined using methods appropriate for noninferiority trials, assuming 90% power and a significance level of 0.05. We performed a pilot study on 18 patients and assessed 100mm VAS on 6 months. Pooled standard deviation was 16.6. To find out whether the hard-soled shoe is not inferior to short leg walking cast for a fifth metatarsal avulsion fracture, 74 patients were required to have 90% power that the lower limit of an one-sided 95% confidence interval for the difference between two treatments will be above the noninferiority margin of -10. We assumed the drop-out rate to be 20%. Adding this number, 96 patients were required for the study.
Determination of the noninferiority margin was based on clinical significance. Todd et al. reported on a study of 48 patients that the minimum clinically significant difference of 100mm VAS was 13mm and that differences of less than this amount, even if statistically significant, are unlikely to be of clinical significance. We decided that the noninferiority margin at 10 mm difference which is less than this amount will be adequate to prove noninferiority of the experiment group (hard-soled shoe) over the control group (short leg walking cast).
After 1 weeks of immobilization in a short leg posterior splint, patients are randomized to experiment group (hard-soled shoe) and control group (short leg walking cast). Randomization was stratified by the study centers. Block randomization were used and the investigators were blinded to the block sizes being used to ensure allocation concealment. Delayed union was defined as a lack of bridging callus on 3 of 5 cortices at 12 weeks. Nonunion was defined as lack of cortical bridging or a clearly visible fracture line, at 14 weeks post injury.
If a subject had discontinued prior to completion of 6 months, the last observation was carried forward for the intent-to-treat analysis. Subjects who crossed over to the other treatment arm, for an example, patients in experiment group(hard-soled shoe) who changed to short leg walking cast or in control group (short leg walking cast) who changed to hard-soled shoe, were analyzed according to their initial group allocation for the intent-to-treat analysis. Additionally, an as-treated (per-protocal) analysis was also conducted on patients who completed the 6 months follow-up with the protocol assigned.
Although previous studied have not documented an increase risk of reduction loss with protected weightbearing in a hard-soled shoe protocol, a safety rule was put in place to assure patients, clinicians, and the health research ethics board that the safety of our patients was a priority. Reduction loss was not a primary outcome, but it was monitored carefully regardless of published evidence. A safety rule established a priori eliminated any dissent among the research team and participating surgeons about stopping the study in the event of an apparent adverse outcome related to protected weightbearing in a hard-soled shoe. If a difference of greater than three spontaneous reduction loss occurred between the groups, the intervention would be halted. A reduction loss or metal failure was defined as one that occurred without patient instigation of inappropriate activity. The reduction loss was to be monitored by study personnel not involved in the outcome assessment.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Hyong Nyun Kim, MD, PhD
- Phone Number: +82-2-829-5165
- Email: hyongnyun@naver.com
Study Locations
-
-
-
Seoul, Korea, Republic of, 150-950
- Recruiting
- Kangnam Sacred Heart Hospital, Hallym University College of Medicine
-
Principal Investigator:
- Hyong Nyun Kim, MD, PhD
-
Contact:
- Hyong Nyun Kim, MD, PhD
- Phone Number: +82-2-829-5165
- Email: hyongnyun@naver.com
-
-
Gyeongi
-
Gunpo, Gyeongi, Korea, Republic of, 435-040
- Recruiting
- Sanbon Hospital, Wonkwang University College of Medicine
-
Contact:
- Yu Mi Kim, MD, PhD
- Phone Number: +82-31-390-2224
- Email: castkim@hanmail.net
-
Seongnam, Gyeongi, Korea, Republic of, 463-712
- Recruiting
- CHA Bundang Medical Center, CHA University
-
Contact:
- Young Rak Choi, MD
- Phone Number: +82-31-780-5298
- Email: jeanguy@hanmail.net
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age between 18 and 65 years
- fifth metatarsal avulsion fracture
Exclusion Criteria:
- open fractures
- pathologic fractures
- a fifth metatarsal avulsion fracture combined with other lower extremity injuries such as Lisfranc injury
- patients with diabetes or neuroarthropathy
- patients with obesity (BMI >30, weight >100 kg)
- any other conditions that are expected to prevent the patients from following the study protocol
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: short leg walking cast
After 1 weeks of immobilization in a short leg posterior splint, patient is allowed protected weightbearing in a short leg walking cast
|
Patients allocated to control group are allowed tolerable weightbearing in a short leg walking cast after one week of immobilization in a posterior splint
|
Experimental: hard-soled shoe
After 1 weeks of immobilization in a short leg posterior splint, patient is allowed tolerable weightbearing in a hard-soled shoe
|
Patients allocated to experiment group are allowed tolerable weightbearing in a hard-soled shoe after one week of immobilization in a posterior splint
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
100mm visual analogue scale (VAS)
Time Frame: 6 months after a fifth metatarsal avulsion fracture
|
The 100mm VAS is widely used self assessment tool for evaluating pain after fracture.
|
6 months after a fifth metatarsal avulsion fracture
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Time to return to preinjury activity
Time Frame: upto 6 months
|
upto 6 months
|
patients' subjective satisfactions
Time Frame: 3, 5, 8, 12 weeks and 6 months after injury
|
3, 5, 8, 12 weeks and 6 months after injury
|
Collaborators and Investigators
Investigators
- Study Chair: Hyong Nyun Kim, MD, PhD, Kangnam Sacred Heart Hospital, Hallym University College of Medicine
- Study Director: Hyong Nyun Kim, MD, PhD, Kangnam Sacred Heart Hospital, Hallym University College of Medicine
Publications and helpful links
General Publications
- Todd KH, Funk KG, Funk JP, Bonacci R. Clinical significance of reported changes in pain severity. Ann Emerg Med. 1996 Apr;27(4):485-9. doi: 10.1016/s0196-0644(96)70238-x.
- Clapper MF, O'Brien TJ, Lyons PM. Fractures of the fifth metatarsal. Analysis of a fracture registry. Clin Orthop Relat Res. 1995 Jun;(315):238-41.
- Gray AC, Rooney BP, Ingram R. A prospective comparison of two treatment options for tuberosity fractures of the proximal fifth metatarsal. Foot (Edinb). 2008 Sep;18(3):156-8. doi: 10.1016/j.foot.2008.02.002. Epub 2008 May 19.
- Heineck J, Wolz M, Haupt C, Rammelt S, Schneiders W. Fifth metatarsal avulsion fracture: a rational basis for postoperative treatment. Arch Orthop Trauma Surg. 2009 Aug;129(8):1089-92. doi: 10.1007/s00402-008-0756-x. Epub 2008 Sep 26.
- Shahid MK, Punwar S, Boulind C, Bannister G. Aircast walking boot and below-knee walking cast for avulsion fractures of the base of the fifth metatarsal: a comparative cohort study. Foot Ankle Int. 2013 Jan;34(1):75-9. doi: 10.1177/1071100712460197.
- Vorlat P, Achtergael W, Haentjens P. Predictors of outcome of non-displaced fractures of the base of the fifth metatarsal. Int Orthop. 2007 Feb;31(1):5-10. doi: 10.1007/s00264-006-0116-9. Epub 2006 May 23.
- Wiener BD, Linder JF, Giattini JF. Treatment of fractures of the fifth metatarsal: a prospective study. Foot Ankle Int. 1997 May;18(5):267-9. doi: 10.1177/107110079701800504.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB2014-OS01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Treatment
-
Psychiatric Centre RigshospitaletAstraZenecaTerminatedMedical Treatment | Antipsychotic Treatment | Quality AssuranceDenmark
-
Vilniaus Implantologijos Centro (VIC) KlinikaInstitut Straumann AGActive, not recruitingSingle Implant; Immediate Implant Treatment; Early Implant TreatmentLithuania
-
Ajman UniversityCompletedTreatmentUnited Arab Emirates
-
Nanjing University School of MedicineCompleted
-
Zagazig UniversityNot yet recruiting
-
Entheon Biomedical Corp.CompletedTreatment-resistant DepressionUnited States
-
Eunice Kennedy Shriver National Institute of Child...Withdrawn
-
The University of Texas Health Science Center at...Patient-Centered Outcomes Research InstituteCompletedStandard Treatment Versus Engagement Focused TreatmentUnited States
-
All India Institute of Medical Sciences, BhubaneswarRecruitingTreatment Resistant SchizophreniaIndia
-
Suzhou Puhe Pharmaceutical Technology Co., LTDRecruitingTreatment Side Effects | TreatmentChina